Guillaume Lessene - Free People Check with News, Pictures & Links

	Australia Melbourne State college

	Professor Research Associate Biology Walter and Eliza Eliza Hall Institute Andrew Medical Research Institute of Medical

Images of Guillaume Lessene

(1 - 1 from 1 )

News

(1 - 4 from 21

–show all

)

Team behind new cancer drug wins prestigious Awardwww.acrf.com.au › news › latest-news › team-behind-new-cancer-trea...

www.acrf.com.au

Professors David Huang and Andrew Roberts and Associate Professors Peter Czabotar, Guillaume Lessene received the award for their roles ...

New tailor-made compound could lead to potential anti ...

in.news.yahoo.com

Dr Guillaume Lessene, Professor Keith Watson and Professor David Huang from the institute's ACRF Chemical Biology division, and Dr Peter ...

Guardian: Women break prize drought by winning five prime ...www.theguardian.com › science › oct › women-break-prize-drought-...

The group of researchers including Peter Czabotar, David Huang, Guillaume Lessene and Andrew Roberts were recognised for their roles in ...

Prime Minister's Prizes for Innovators and Innovation ABCwww.abc.net.au › radionational › programs › scienceshow

www.abc.net.au

The winners are professors Peter Czabotar, David Huang, Guillaume Lessene and Andrew Roberts. The New Innovators Prize goes to Luke ...

Telephone & Addresses

Guillaume L Lessene, State College, Waupelani Dr

View Guillaume's social profiles and photos on Facebook, MySpace, and +40 Networks.

Physicians & MDs

Krebs: Wichtiger Durchbruch bei der Krebstherapie? – Heilpraxis

www.heilpraxisnet.de

Durch eine gezielte Behandlung von MLC1 werden im Grund die betroffenen Krebszellen komplett abgetötet, erklärt Professor Guillaume Lessene vom Walter and Eliza Hall Institute. Behandlung besonders effektiv bei verschiedenen Arten von Blutkrebs Es hat sich außerdem gezeigt, dass diese Art der ...

Network Profiles

Professor Guillaume Lessene | WEHI

www.wehi.edu.au

Our laboratory applies medicinal chemistry and chemical biology approaches to basic and translational research.

Lessene-Achievements | WEHI

vcwww-prod.wehi.edu.au

Professor Guillaume Lessene awards

Lessene-Lab team | Walter and Eliza Hall Institute of Medical Research

www.wehi.edu.au

Associate Professor Guillaume Lessene lab team

Interests

(1 - 4 from 5

–show all

)

Anti-cancer compound wins scientist Biota Award | EurekAlert! Science...

www.eurekalert.org

Walter and Eliza Hall Institute of Medical Research scientist Dr Guillaume Lessene has won this year's Biota Award for Medicinal Chemistry, awarded by the...

New anti-inflammatory molecule could halt MS progression ...www.sciencedaily.com › releases ›

www.sciencedaily.com

Dr Ueli Nachbur, Associate Professor John Silke, Associate Professor Guillaume Lessene, Professor Andrew Lew and colleagues developed ...

Cancer 'breakthrough' could help millions | SBS News

www.sbs.com.au

Australian researchers say a newly discovered compound shows promise in treating a diverse range of cancers, particularly acute myeloid leukaemia.

Australian discovery a 'big step' towards new anti-cancer drug

www.smh.com.au

Australian scientists have helped create a compound they believe will lead to a new, more effective cancer fighting drug.

Business Profiles

Researchgate: Guillaume Lessene

Melbourne, VIC, Australia

Books & Literature

A DUAL BH3-MIMETIC APPROACH TARGETING BOTH BCL-2 AND MCL1 IS...

library.ehaweb.org

Instantly find & access educational materials and complete eLearning activities at your leisure. Native iPad/iPhone/Android Apps are available for the...

Histoire de la ville de Rouen: divisée en six parties - Ignace...

books.google.de

... furent donnez par diverses personnes. L'an l'orgue fut construit par Guillaume Lessene Ecossois , & l'an 162o. la Croix qui est au milieu du Cloître , y fut mise en ...

Scientific Publications

BAX-BAK1-independent LC3B lipidation by BH3 mimetics is unrelated to...

www.ncbi.nlm.nih.gov

BAX-BAK1-independent LC3B lipidation by BH3 mimetics is unrelated to BH3 mimetic activity and has only minimal effects on autophagic flux. Boris Reljic,a,b Stephanie Conos,a,b Erinna F. Lee,b,c,d,e,f Jean-Marc Garnier,b,g Li Dong,a,bGuillaume Lessene,b,g,h W. Douglas Fairlie,b,c,d,e,f David L. Vaux ...

iTWire - Anti-cancer drug wins scientists PM's innovation award

www.itwire.com

Four scientists from the Walter & Eliza Hall Institute of Medical Research have won the Prime Minister's Prize for Innovation, one of the seve...

This New Compound Could Help Kill Up to a Quarter of All Cancer Types

www.sciencealert.com

Wow.

Publications

Publications Authored by Guillaume Lessene | PubFacts

www.pubfacts.com

Publications Authored by Guillaume Lessene

Reports & Statements

Control of apoptosis by the BCL-2 protein family: implications for...

www.nature.com

...

January – Apoptosis and cell death

celldeath.wordpress.com

1 post published by cris during January 2015

Structure-guided design of a selective BCL-XL inhibitor | Nature...

www.nature.com

A high-throughput chemical screen followed by structure-guided chemical design leads to the first potent and selective small-molecule BCL-XL inhibitor.

Miscellaneous

(1 - 20 from 45

–show all

)

Guillaume Lessene Archives - NFMRINFMRIwww.nfmri.org.au › tag › guillaume-lessene

nfmri.org.au

Tag: Guillaume Lessene. NFMRI unveils grant recipients. 11th December In the presence of industry, business and research experts and our partner ...

Guillaume Lessene | RxNetwww.rx-network.com › users › guillaume-lessene

www.rx-network.com

Go to the profile of Guillaume Lessene. Guillaume Lessene. Division Head, The Walter and Eliza Hall Institute of Medical Research. Follow Share this profile.

guillaume lessene - BAOMOI.COM

baomoi.com

guillaume lessene. Phát hiện hợp chất mới có thể tiêu diệt tế bào ung thư mà không gây phản ứng phụ · ĐS&PL liên quan Phát hiện hợp chất mới có thể tiêu diệt tế bào ung thư mà không gây phản ứng phụ. Một tin vui mang lại hy vọng cho những bệnh nhân đang đau khổ chống chọi với căn bệnh quái ác, các ...

Guillaume Lessene, PhD | Parkinson's Disease

www.michaeljfox.org

Dr. Guillaume Lessene was trained as an organic chemist. In 2001, he joined the then newly created Medicinal Chemistry laboratory at the Walter and Eliza Hall ...

Professor Guillaume Lessene - Latest research stories and ...pursuit.unimelb.edu.au › individuals › professor-guillaume-lessene

pursuit.unimelb.edu.au

Professor Guillaume Lessene. Head, New Medicines and Advanced Technologies theme, Walter and Eliza Hall Institute of Medical Research; ...

SELECTBIO - Screening Asia Speaker Biography

selectbiosciences.com

Guillaume Lessene, Head of Laboratory, The Walter and Eliza Hall Institute of Medical Research. Associate Professor Guillaume Lessene jointly heads the ACRF Chemical

Guillaume Lessene — ASN Events

cancer-2017.p.asnevents.com.au

... Conference Days; Thursday, 9th February · Friday, 10th February · Saturday, 11th February. Search; Speakers. Guillaume Lessene. Abstracts this author is presenting: Targeting BCL-2 family proteins to treat cancer: expanding the repertoire of small molecules BH3-mimetics — Session 1: Targeting Bcl2 family.

A/Pr Guillaume Lessene - Research Data Australiaresearchdata.ands.org.au › apr-guillaume-lessene

researchdata.edu.au

Principal investigator of Principal investigator of Principal investigator of Principal investigator of Principal investigator of Participant in Participant in Principal ...

A New Multiple Sclerosis Treatment On The Horizon? Anti-Inflammatory...

www.medicaldaily.com

A molecule known as WEHI-345 shows potential in fighting inflammation, something that could help prevent or halt multiple sclerosis.

A perspective on 10-years HTS experience at the Walter and Eliza Hall...

research.monash.edu

Kurt P Lackovic, Guillaume Lessene, Hendrik Falk, Karl-Johan Leuchowius, Jonathan Bayldon Baell, Ian Philip Street. Medicinal Chemistry. Research output: ...

A Perspective on 10-Years HTS Experience at the Walter and Eliza Hall...

www.eurekaselect.com

A Perspective on 10-Years HTS Experience at the Walter and Eliza Hall Institute of Medical Research – Eighteen Million Assays and Counting. Author(s): Kurt Lackovic, Guillaume Lessene, Hendrik Falk, Karl-Johan Leuchowius, Jonathan Baell, Ian Street. Division of Systems Biology and Personalized Medicine, Walter and ...

Altmetric – A RIPK2 inhibitor delays NOD signalling events yet...

www.altmetric.com

... Lowes, James M. Murphy, Mads Gyrd-Hansen, Michael W. Parker, Elizabeth L. Hartland, Andrew M. Lew, David C. S. Huang, Guillaume Lessene, John Silke.

New anti-inflammatory molecule could halt MS progression

healthmedicinet.com

IMAGE: Associate Professor Guillaume Lessene, Dr Ueli Nachbur, Professor Andrew Lew (L-R) and colleagues developed a new drug-like molecule that prevents inflammation

Advances in the Negishi Coupling - CSIRO Publishingwww.publish.csiro.au › pdf

www.publish.csiro.au

Guillaume Lessene studied chemistry at the Ecole Nationale Supérieure de Chimie in Paris, where he received his Honours degree in

Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN...

www.semanticscholar.org

Mark F. van Delft,2,5 Sammy Bedoui,6 Guillaume Lessene,1,5,7 Matthew E. Ritchie,3,5,8 David C.S. Huang,2,5 and Benjamin T. Kile1,5,*. 1ACRF Chemical Biology Division. 2Cancer and Haematology Division. 3Molecular Medicine Division. 4Molecular Genetics of Cancer Division. The Walter and Eliza ...